Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?

Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.

Saved in:
Bibliographic Details
Main Authors: Fátima de Menezes Dantas, Felipe Olobardi Freire, Agábio Diógenes Pessoa Neto, Clécio de Oliveira Godeiro Júnior, Rodrigo Alencar e Silva
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2025-01-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1793935
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846091025323393024
author Fátima de Menezes Dantas
Felipe Olobardi Freire
Agábio Diógenes Pessoa Neto
Clécio de Oliveira Godeiro Júnior
Rodrigo Alencar e Silva
author_facet Fátima de Menezes Dantas
Felipe Olobardi Freire
Agábio Diógenes Pessoa Neto
Clécio de Oliveira Godeiro Júnior
Rodrigo Alencar e Silva
author_sort Fátima de Menezes Dantas
collection DOAJ
description Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.
format Article
id doaj-art-94c413e14b3d4936add7677e73a8e8b5
institution Kabale University
issn 0004-282X
1678-4227
language English
publishDate 2025-01-01
publisher Academia Brasileira de Neurologia (ABNEURO)
record_format Article
series Arquivos de Neuro-Psiquiatria
spelling doaj-art-94c413e14b3d4936add7677e73a8e8b52025-01-15T23:30:31ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria0004-282X1678-42272025-01-01830100100810.1055/s-0044-1793935Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?Fátima de Menezes Dantas0https://orcid.org/0000-0003-4766-7825Felipe Olobardi Freire1https://orcid.org/0009-0004-4119-7599Agábio Diógenes Pessoa Neto2https://orcid.org/0000-0003-2937-5298Clécio de Oliveira Godeiro Júnior3https://orcid.org/0000-0002-4312-1633Rodrigo Alencar e Silva4https://orcid.org/0000-0002-3311-0164Universidade Federal do Rio Grande do Norte, Centro de Ciências da Saúde, Natal RN, Brazil.Universidade Federal do Rio Grande do Norte, Centro de Ciências da Saúde, Natal RN, Brazil.Instituto de Ensino e Pesquisa Alberto Santos Dumont, Ambulatório Multiprofissional de Doença de Parkinson, Macaíba RN, Brazil.Universidade Federal do Rio Grande do Norte, Hospital Universitário Onofre Lopes, Serviço de Neurologia, Natal RN, Brazil.Universidade Federal do Rio Grande do Norte, Hospital Universitário Onofre Lopes, Serviço de Neurologia, Natal RN, Brazil. Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1793935Hemifacial SpasmBotulinum ToxinsBotulinum Toxins, Type A
spellingShingle Fátima de Menezes Dantas
Felipe Olobardi Freire
Agábio Diógenes Pessoa Neto
Clécio de Oliveira Godeiro Júnior
Rodrigo Alencar e Silva
Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
Arquivos de Neuro-Psiquiatria
Hemifacial Spasm
Botulinum Toxins
Botulinum Toxins, Type A
title Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
title_full Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
title_fullStr Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
title_full_unstemmed Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
title_short Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
title_sort dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm is there modification during follow up
topic Hemifacial Spasm
Botulinum Toxins
Botulinum Toxins, Type A
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1793935
work_keys_str_mv AT fatimademenezesdantas dosageofbotulinumtoxininpatientsundergoingtreatmentforhemifacialspasmistheremodificationduringfollowup
AT felipeolobardifreire dosageofbotulinumtoxininpatientsundergoingtreatmentforhemifacialspasmistheremodificationduringfollowup
AT agabiodiogenespessoaneto dosageofbotulinumtoxininpatientsundergoingtreatmentforhemifacialspasmistheremodificationduringfollowup
AT cleciodeoliveiragodeirojunior dosageofbotulinumtoxininpatientsundergoingtreatmentforhemifacialspasmistheremodificationduringfollowup
AT rodrigoalencaresilva dosageofbotulinumtoxininpatientsundergoingtreatmentforhemifacialspasmistheremodificationduringfollowup